Lotus Pharmaceutical Co., Ltd. (1795) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Lotus Pharmaceutical Co., Ltd. (1795:TWSE), powered by AI.

Current Price
$193.50
Sector
Healthcare
What is the Lotus Pharmaceutical Co., Ltd. stock price forecast?

Lotus Pharmaceutical Co., Ltd. is currently trading at $193.50. View real-time AI analysis on Alpha Lenz.

What is Lotus Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Lotus Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Lotus Pharmaceutical Co., Ltd.'s P/E ratio?

View Lotus Pharmaceutical Co., Ltd.'s valuation metrics on Alpha Lenz.

Lotus Pharmaceutical Co., Ltd.

TWSE · 1795
NT$193.50+2.50(+1.31%)
Ask about Lotus Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Lotus Pharmaceutical Co., Ltd.'s ROE is 21.0%. Explore profitability and growth together.

Ask for details

Company Overview

Lotus Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the development, manufacture, and sale of a wide range of healthcare products. Its primary function is to produce generic and specialty pharmaceuticals that cater to the healthcare needs across various therapeutic areas. Lotus Pharmaceutical focuses on delivering high-quality and affordable medication solutions, positioning itself as a key provider in both domestic and international markets. The company operates within the dynamic pharmaceutical sector, impacting industries such as health and wellness, biotechnology, and medical research. With a commitment to innovative drug development and strategic partnerships, Lotus Pharmaceutical plays a vital role in improving patient outcomes and expanding access to essential medications worldwide. Founded with a mission to address diverse medical needs, the company sustains its growth through robust research and development efforts and a broad manufacturing and distribution network. As a significant player in the pharmaceutical landscape, Lotus Pharmaceutical Co., Ltd. contributes notably to global healthcare advancements.

CEOMr. Petar Antonov Vazharov
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$20.51BRevenue
0.00Shares Out
0Employees

Margins

58.05%Gross
39.69%EBITDA
28.75%Operating
27.88%Pre-Tax
23.01%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

11.91%Rev 3Yr
13.84%Rev 5Yr
12.80%Op Inc 3Yr
29.61%Op Inc 5Yr
16.04%Net Inc 3Yr
35.60%Net Inc 5Yr

Returns

6.45%ROA
21.00%ROE
9.04%ROIC

Financial Health

NT$7.74BCash & Cash Equivalents
NT$74.63BNet Debt
346.40%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Lotus Pharmaceutical Co., Ltd. (ticker: 1795) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).

The current price is 193.5 with a P/E ratio of -x and P/B of -x.

ROE is 21.00% and operating margin is 28.75%. Annual revenue is $20.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Lotus Pharmaceutical Co., Ltd. (1795) Stock Forecast 2026 $193.50 — Price, Financials & Analyst Targets | Alpha Lenz